230 related articles for article (PubMed ID: 12422934)
1. Hallucinogens and redemption.
de Rios MD; Grob CS; Baker JR
J Psychoactive Drugs; 2002; 34(3):239-48. PubMed ID: 12422934
[TBL] [Abstract][Full Text] [Related]
2. Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca.
Winkelman M
Curr Drug Abuse Rev; 2014; 7(2):101-16. PubMed ID: 25563446
[TBL] [Abstract][Full Text] [Related]
3. Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society.
Blainey MG
J Relig Health; 2015 Feb; 54(1):287-302. PubMed ID: 24477460
[TBL] [Abstract][Full Text] [Related]
4. Dependence on LSD and other hallucinogenic drugs.
JAMA; 1967 Oct; 202(1):141-4. PubMed ID: 6072003
[No Abstract] [Full Text] [Related]
5. Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges.
Labate BC; Feeney K
Int J Drug Policy; 2012 Mar; 23(2):154-61. PubMed ID: 21856141
[TBL] [Abstract][Full Text] [Related]
6. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.
Halpern JH; Sherwood AR; Passie T; Blackwell KC; Ruttenber AJ
Med Sci Monit; 2008 Aug; 14(8):SR15-22. PubMed ID: 18668010
[TBL] [Abstract][Full Text] [Related]
7. Peyote use during pregnancy.
Gilmore HT
S D J Med; 2001 Jan; 54(1):27-9. PubMed ID: 11211421
[TBL] [Abstract][Full Text] [Related]
8. Report on psychoactive drug use among adolescents using ayahuasca within a religious context.
Doering-Silveira E; Grob CS; de Rios MD; Lopez E; Alonso LK; Tacla C; Da Silveira DX
J Psychoactive Drugs; 2005 Jun; 37(2):141-4. PubMed ID: 16149326
[TBL] [Abstract][Full Text] [Related]
9. [Narcotics abuse in adolescents].
Leuner H
Nervenarzt; 1971 Jun; 42(6):281-91. PubMed ID: 4931883
[No Abstract] [Full Text] [Related]
10. Immunological effects of ayahuasca in humans.
dos Santos RG
J Psychoactive Drugs; 2014; 46(5):383-8. PubMed ID: 25364989
[TBL] [Abstract][Full Text] [Related]
11. Ayahuasca in adolescence: Qaualitative results.
de Rios MD; Grob CS; Lopez E; da Silviera DX; Alonso LK; Doering-Silveira E
J Psychoactive Drugs; 2005 Jun; 37(2):135-9. PubMed ID: 16149325
[TBL] [Abstract][Full Text] [Related]
12. The "vine of the soul" vs. the Controlled Substances Act: implications of the hoasca case.
Bullis RK
J Psychoactive Drugs; 2008 Jun; 40(2):193-9. PubMed ID: 18720669
[TBL] [Abstract][Full Text] [Related]
13. [Gynecological-obstetrical problems in female drug users and drug addicts].
Zumbé FJ; Beck KJ; Schönhöfer PS
Geburtshilfe Frauenheilkd; 1973 Apr; 33(4):241-53. PubMed ID: 4710014
[No Abstract] [Full Text] [Related]
14. [Ayahuasca - religion, life-style or drug?].
Neu P
Fortschr Neurol Psychiatr; 2020 Oct; 88(10):669-673. PubMed ID: 32544955
[TBL] [Abstract][Full Text] [Related]
15. A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects.
Barbosa PC; Cazorla IM; Giglio JS; Strassman R
J Psychoactive Drugs; 2009 Sep; 41(3):205-12. PubMed ID: 19999673
[TBL] [Abstract][Full Text] [Related]
16. Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives.
Labate BC
J Psychoactive Drugs; 2011; 43(1):27-35. PubMed ID: 21615005
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078
[TBL] [Abstract][Full Text] [Related]
18. Drug dreams in mescaline and LSD addiction.
Colace C
Am J Addict; 2010; 19(2):192. PubMed ID: 20163393
[No Abstract] [Full Text] [Related]
19. Examination of Recreational and Spiritual Peyote Use Among American Indian Youth.
Prince MA; O'Donnell MB; Stanley LR; Swaim RC
J Stud Alcohol Drugs; 2019 May; 80(3):366-370. PubMed ID: 31250802
[TBL] [Abstract][Full Text] [Related]
20. From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide.
Smith DE; Raswyck GE; Davidson LD
J Psychoactive Drugs; 2014; 46(1):3-10. PubMed ID: 24830180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
